Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dystrophies, Landouzy-Dejerine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Not applicableStudy completedNCT02159612
What this trial is testing

1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Grete Andersen, MD 45
Testing effectiveness (Phase 2)Study completedNCT02579239
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Limb-Girdle Muscular DystrophiesFacioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 18
Not applicableLooking for participantsNCT05019625
What this trial is testing

Biomarker Development for Muscular Dystrophies

Who this might be right for
Myotonic DystrophyDuchenne Muscular DystrophyBecker Muscular Dystrophy+1 more
Massachusetts General Hospital 465
Testing effectiveness (Phase 2)Study completedNCT02836418
What this trial is testing

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular DystrophyLimb Girdle Muscular Dystrophy
aTyr Pharma, Inc. 8
Not applicableStudy completedNCT00004685
What this trial is testing

Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Ohio State University 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT06222827
What this trial is testing

Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Centre Hospitalier Universitaire de Nice 46
Not applicableEnded earlyNCT06096441
What this trial is testing

FSHD Molecular Characterization

Who this might be right for
Facio-Scapulo-Humeral Dystrophy
Nationwide Children's Hospital 1
Testing effectiveness (Phase 2)Ended earlyNCT02927080
What this trial is testing

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 95
Not applicableStudy completedNCT06785428
What this trial is testing

Dietary Protein Requirements in Adults With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Fascioscapulohumeral Muscular Dystrophy
McGill University 10
Not applicableStudy completedNCT02766985
What this trial is testing

Rasch-analysis of Clinical Severity in FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University of Kansas Medical Center 44
Not applicableLooking for participantsNCT00082108
What this trial is testing

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Who this might be right for
Myotonic DystrophyFacioscapulohumeral Muscular DystrophyMuscular Dystrophy+6 more
University of Rochester 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT07435129
What this trial is testing

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

Who this might be right for
Facioscapulohumeral Muscular DystrophyFSHD
Scholar Rock, Inc. 60
Not applicableStudy completedNCT02948244
What this trial is testing

Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHD

Who this might be right for
Facio-Scapulo-Humeral DystrophyFSHD2FSHD1
Murdoch Childrens Research Institute 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07798609
What this trial is testing

A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Soufflé Therapeutics, Inc. 90
Not applicableStudy completedNCT04377217
What this trial is testing

Computerized Facial Recognition for Automated Diagnosis of the Facio-Scapulo-Humeral Muscular Dystrophy (FSMHD)

Who this might be right for
Facio-Scapulo-Humeral Dystrophy
Centre Hospitalier Universitaire de Nice 17
Testing effectiveness (Phase 2)Study completedNCT04003974
What this trial is testing

Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 80
Testing effectiveness (Phase 2)Study completedNCT02531217
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 9
Testing effectiveness (Phase 2)Ended earlyNCT04264442
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 76
Not applicableStudy completedNCT04999735
What this trial is testing

Digital Biotyping of FSHD Patients and Controls

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Centre for Human Drug Research, Netherlands 58